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Primary angiosarcoma of the aorta is a rare
malignancy arising from the aorta’s endothelial lining.
The most common presentation is claudication,
however in the presence of an endograft a tumor
originating in the aneurysmal sac may remain
undetected and mimic common graft pathology1,2.
Diagnosis is typically delayed due to vague clinical
presentation and imaging being indistinguishable from
common complications of endografts such as leaks,
infections or hematomas. We report a case of primary
angiosarcoma of the aorta after endovascular repair
of an abdominal aortic aneurysm. This case report
describes the sixth case in the literature of primary
angiosarcoma arising after the placement of an
endovascular stent2–5.
INTRODUCTION
Rare Presentation of High Grade Retroperitoneal 
Angiosarcoma in a Patient Status Post Endovascular Aortic 
Repair
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A 75 year-old male with a previous history of
endovascular aortic repair for a AAA six years prior
presented to the emergency room with signs and
symptoms concerning for bowel obstruction. He
elicited abdominal pain, nausea, emesis, obstipation
and was anemic and had leukocytosis. A CT angiogram
of the abdomen and pelvis displayed a large mass
encasing the infra-renal aorta, without active
extravasation, that was externally compressing the
second portion of the duodenum and causing a gastric
outlet obstruction.
Angiosarcoma is a rare malignancy representing 2% of
all soft tissue sarcomas; associated with a poor
prognosis with a median survival time of seven to
eight months in advanced tumors. 6,7,8 Tumors larger
than 5cm and those located in the retroperitoneum,
such as in the case report that we present, are
associated with a poor prognosis.9 Doxorubicin is the
mainstay of treatment for locally advanced tumors.10
Paclitaxel has also been shown to be effective.6 We
present this care report to increase cognizance of this
rare entity in the setting of a previously placed aortic
endograft and avoid unnecessary surgical
interventions.
The mass extended into both iliac arteries with
extension into a right iliac artery aneurysm. Review of
the patient’s chart revealed that this mass was not
present six months prior. Patient was treated non-
operatively with placement of a nasogastric tube.
Concerns for a Type I or III Endoleak delayed the
eventual CT-guided biopsy of the mass. Pathology
revealed a malignant spindled and pleomorphic mass
with extensive hemorrhage and necrosis consistent
with high grade angiosarcoma. Specimen tested
positive for vimentin, CD68, ERG, and CD31 on
immunohistochemical staining. Patient did not wish to
undergo aggressive treatment and was discharged to a
hospice facility where he expired days later.
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